Soluble endoglin exacerbates bile acid retention during labetalol treatment in mice with ethinylestradiol-induced cholestasis
Sá, I. Igreja, Tripská, K., Faradonbeh, F.A., Hroch, M., Lastuvkova, H., Kacerovsky, M., Pericacho, M., Nachtigal, P., Micuda, S.
Published in Atherosclerosis (01.08.2023)
Published in Atherosclerosis (01.08.2023)
Get full text
Journal Article
Soluble endoglin is a biomarker of various types of liver damage
Eissazadeh, S., Faradonbeh, F.A., Rathouská, J.R., Němečková, I., Mohammadi, S., Sá, I. Igreja, Fikrová, P.F., Nachtigal, P.
Published in Atherosclerosis (01.08.2023)
Published in Atherosclerosis (01.08.2023)
Get full text
Journal Article